Publications by authors named "Ronan McLaughlin"

Claim this Profile
D
Disrupting CDK9 activity suppresses triple-negative breast cancer and is enhanced by EGFR Inhibition.
Vera E van der Noord, Ronan P McLaughlin, Jessica S Karuntu, Jichao He, A Mieke Timmermans

Cell Oncol (Dordr)· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer.
Jennifer J Knox, Grainne O'Kane, Daniel King, Daniel Laheru, Amber N Habowski, Ronan A McLaughlin

J Clin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer.
Jennifer J Knox, Grainne O'Kane, Daniel King, Daniel Laheru, Amber N Habowski, Ronan A McLaughlin

J Clin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Operational determinants of recruitment and biospecimen collection in translational observational studies: a multi-site comparative analysis.
Ciarán Devoy, Ronan Andrew McLaughlin, Christopher Cronin, Rachel Clarke, Roisin M Connolly

J Transl Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant chemoradiation in older Irish adult patients with oesophageal cancer: a retrospective institutional review of clinical outcomes and hematological toxicity.
Ronan Andrew McLaughlin, David McMahon, Christopher Cluxton, Orla Meave Fitzpatrick, Michael Conroy

BMC Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Pre-Diagnostic Delay and Survival Among Patients With Esophageal and Gastric Cancer Treated With Curative Intent During the COVID19 Pandemic.
Xin Wang, Yvonne Bach, Katherine Lajkosz, Osvaldo Espin-Garcia, Hiroko Aoyama, Ronan McLaughlin

Cancer Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ramucirumab and paclitaxel in second or greater lines of therapy in patients with HER2-positive gastroesophageal cancer: a single center study.
Yvonne Bach, Divya Sharma, Hiroko Aoyama, Lucy X Ma, Carly C Barron, Ronan McLaughlin

Oncologist· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is Immunotherapy Beneficial in Patients with Oncogene-Addicted Non-Small Cell Lung Cancers? A Narrative Review.
David John McMahon, Ronan McLaughlin, Jarushka Naidoo

Cancers (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost and public reimbursement of cancer medicines in the UK and the Republic of Ireland.
David O'Reilly, Ronan McLaughlin, Cian Ronayne, Anne Marie De Frein, Bojan Macanovic

Ir J Med Sci· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: -inhibitor therapy in -mutated primary CNS tumours including one case of -mutated disease.
Christopher Cronin, Ronan McLaughlin, Louise Lane, Francesca M Brett, Michael Jansen

Front Med (Lausanne)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virtual oncology clinics during the COVID-19 pandemic.
David O'Reilly, Hailey Carroll, Mairi Lucas, Jane Sui, Maha Al Sendi, Ronan McLaughlin

Ir J Med Sci· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid and Laboratory SARS-CoV-2 Antibody Testing in High-Risk Hospital Associated Cohorts of Unknown COVID-19 Exposure, a Validation and Epidemiological Study After the First Wave of the Pandemic.
Brendan O'Kelly, Ronan McLaughlin, Roseann O'Doherty, Hailey Carroll, Roisin Murray

Front Med (Lausanne)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative analysis of genomic amplification-dependent expression and loss-of-function screen identifies ASAP1 as a driver gene in triple-negative breast cancer progression.
Jichao He, Ronan P McLaughlin, Lambert van der Beek, Sander Canisius, Lodewyk Wessels

Oncogene· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer.
Jichao He, Ronan P McLaughlin, Vera van der Noord, John A Foekens, John W M Martens

Breast Cancer Res Treat· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An increased cell cycle gene network determines MEK and Akt inhibitor double resistance in triple-negative breast cancer.
Vera E van der Noord, Ronan P McLaughlin, Marcel Smid, John A Foekens, John W M Martens

Sci Rep· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapy.
Ronan P McLaughlin, Jichao He, Vera E van der Noord, Jevin Redel, John A Foekens

Breast Cancer Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis